Drug delivery describes the tactic ANd approach to delivering medicine or prescription drugs and alternative xenobiotics to their web site of action among an organism, with the goal of achieving a therapeutic outcome. problems with pharmacodynamics and pharmacology square measure necessary concerns for drug delivery.

Biochempeg PEGylation linkers, by increasing the molecular weight of a molecule, can impart several significant pharmacological advantages over the unmodified form, such as improved drug solubility, reduced dosage frequency, without diminished efficacy with potentially reduced toxicity, extended circulating life, increased drug stability, and enhanced protection from proteolytic degradation
Biochempeg provide bulk maleimide,  pyridyl disulfide, amine, carboxylic acids and NHS esters  functionalized PEG which can linked with proteins, typical reactive amino acids include lysine, cysteine, histidine, arginine, aspartic acid, glutamic acid, serine, threonine, tyrosine.

Catalog No.	Name	Structure	M.W.	Purity	Buy
MF001003	mPEG-SH			≥95%	BUY
MF001004	mPEG-CHO			≥95%	BUY
MF001017	mPEG-COOH			≥95%	BUY
MF001022	mPEG-Mal			≥95%	BUY
MF001023	mPEG-SC			≥95%	BUY
MF001024	mPEG-SCM			≥95%	BUY
MF001050	mPEG-NH2.HCl			≥95%	BUY
HE005017	NH2-PEG-COOH			≥95%	BUY
HE017050	COOH-PEG-NH2.HCl			≥95%	BUY
HE022002	Mal-PEG-OH			≥95%	BUY
HE022024	Mal-PEG-SCM			≥95%	BUY
HE022123	Mal-NH-PEG-NH2.TFA			≥95%	BUY